Indeed, sFRP1 has also been shown to impact on transforming properties of breast cancer cells [6,29] and cervix cancer cells [36]; while sFRP2 has been shown to block proliferation of gastric cancer cells [37]. The gene discussed is SFRP2; the disease is gastric cancer.